U.S. Gov't Will Legalize Doctor's Marijuana on August 1st

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone
U.S. Gov't Will Legalize Doctor's Marijuana on August 1st 2016



The U.S. Drug Enforcement Administration will reclassify marijuana as a "Schedule Two" drug on August 1, 2016, essentially legalizing medicinal cannabis in all 50 states with a doctor's prescription, said a DEA lawyer with knowledge of the matter.

The DEA Lawyer had told the lawyer representing a DEA informant of the DEA's plan to legalize medicinal cannibis nationwide on August 1, 2016. When questioned by our reporter, the DEA lawyer felt compelled to admit the truth to him as well.

"Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states," the DEA attorney told the Observer. Federal Preemption is a legal doctrine that where the US Government regulates a particular field, State and local laws are overridden and of no effect.

He explained that "there are five DEA schedules. Nothing on Schedule One is ever legal, and that is where Cannabis is today. Schedule Two drugs are available with a prescription."

On Schedule Two, marijuana will join drugs like Percocet, Xanax, Oxycontin, Abilify and other drugs that are legal, even common, with a prescription. There are also other drugs that are not on any schedules but that are illegal on a federal level, he said. Drugs like aspirin and ibuprofen are available over-the-counter.

He opined that the 135 medicinal cannabis clinic owners in Los Angeles will no doubt oppose this move by the Federal government, because the rule change will eliminate any reason for people to visit medical marijuana clinics. "In my opinion, CVS pharmacy, Rite-Aid and Walgreens will sell Schedule Two THC products similar to what users call "edibles," but will not sell smokable weed because of the health risk smoking anything entails," said the DEA lawyer.

The Los Angeles based DEA Attorney who spoke to us, asked to remain anonymous because he was not authorized to speak to the press about the matter. He speculated that this action will be taken in the closing days of the 2016 U.S. Presidential election, so as to motivate the Democratic base to turn out and vote for Hillary Clinton, and other down ballot candidates. She will certainly not reverse this policy decision taken in the waning days of the Barack Obama administration, he said. But Donald Trump might.

"Marijuana enforcement is a big drain on DEA resources," he said was another reason for the change, noting that a majority of the American public favor the legalization of marijuana for medical use.

Libertarian candidate Gary Johnson is in favor of legalizing marijuana and in fact owns a business which pedals pot in New Mexico.

California will vote on November 7th, 2016, whether to legalize the recreational use of marijuana. Because of Federal preemption, the DEA's reclassification of cannabis as a Schedule Two drug, will have the legal effect of requiring a prescription in California--i.e., it will continue the status quo.

Since the Golden State legalized medical marijuana almost 20 years ago, Federal authorities have occasionally raided medical marijuana clinics here. They have forced major banks, like Bank of America, to close clinic bank accounts. The Feds have even seized real estate belonging to landlords who rent space to pot clinics. The Federal war on medicinal marijuana will abruptly end on August 1, 2016.

8/01 is the new 4/20!

Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; However, there is no single agreed upon definition, says Wikipedia. The use of cannabis as a medicine has not been rigorously scientifically tested, often due to production restrictions and other governmental regulations. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications, however, is insufficient for conclusions about safety or efficacy.

In California, there are "weed doctors" who will write a prescription for cannabis to anyone claiming to suffer from anxiety, which means they passout prescriptions for pot like chocolate bars at a Halloween party. As with so many other trends that started in California, expect to see medicinal marijuana sold in your town soon!

Medical cannabis can be administered using a variety of methods, including liquid tinctures, vaporizing or smoking dried buds, eating cannabis edibles, taking capsules, using lozenges, dermal patches or oral/dermal sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone.

Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Australia, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands (where it is also legal recreationally), Portugal and Spain.

In the United States, federal law outlaws all cannabis use, while 25 states and the District of Columbia no longer prosecute individuals for the possession or sale of medical marijuana, as long as the individuals are in compliance with the state's medical marijuana sale regulations.

The DEA lawyer gave us his legal opinion that if you happen to live where recreational marijuana is now legal, i.e. Colorado or Washington State; after August 1, you will need a prescription, as you would need throughout the U.S.

However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.

As explained above, moving marijuana from Schedule One to Schedule Two, would have the effect of legalizing medicinal marijuana, throughout all 50 States, the District of Columbia and U.S. territories. This action may be taken by the DEA unilaterally--i.e., without specific Congressional authorization -- because Congress has previously granted the DEA rule-making authority over what drugs are on which schedules.

The Drug Enforcement Administration (DEA) is a United States federal law enforcement agency under the U.S. Department of Justice, tasked with combating drug smuggling and use within the United States. Not only is the DEA the lead agency for domestic enforcement of the Controlled Substances Act, sharing concurrent jurisdiction with the Federal Bureau of Investigation (FBI) and Immigration and Customs Enforcement (ICE), it also has sole responsibility for coordinating and pursuing U.S. drug investigations abroad.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 6

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
Dr. Liedtka's LIVE Model: Balance Life’s Priorities

Updated Category News Views 3

Finding Balance in a Chaotic World Forget the market roller coaster for a second. Let's chat about something else that often feels like a roller coaster—life itself. Dr. Karl D. Liedtka's book, "Be Present, LIVE Fully," dives into that hot mess and offers a way to get a grip on your own sanity. This isn't just another self-help book filled with empty platitudes; it's...

Continue Reading
Hoymiles' V2X Charger Revamps Home Energy Control

Updated Category News Views 4

Revolutionizing Home Energy with Hoymiles Here's a twist in the world of home energy that'll make any enthusiast pause—Hoymiles has launched their V2X DC Charger. This little number isn’t just a step up; it’s a giant leap toward integrating electric vehicles (EVs) into your home's energy system like never before. Nestled in Hangzhou, they've rolled this out as a...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 3

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Potensic's ATOM 3 Invites Drone Creators to 'See Beyond'

Updated Category News Views 5

Innovative Features of Potensic's New Drone Potensic decided to shake things up a bit this year at IFA Berlin, showcasing their new creation: the ATOM 3 drone. Under the theme "SEE BEYOND," Potensic’s message to creators was clear—there’s more to explore in the world of visual storytelling than meets the eye. This drone isn't just another gadget; it's an invitation...

Continue Reading
FOTON Accelerates Global Push with European Focus

Updated Category News Views 4

The Road to Global Dominance Ever feel like someone’s racing past you while others try to catch up? That’s FOTON in the relentless world of commercial vehicles. This juggernaut of a company isn't just satisfied with leading the pack; they’ve got their eyes set on redefines the game, especially with their new moves in Europe. A Shift in Strategy Right now, the...

Continue Reading
Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Updated Category News Views 3

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

Continue Reading
AION UT Sets New Safety Standard in Euro NCAP 2026

Updated Category News Views 4

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 1

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
AB SKF to Hold EGM, Spin Off Automotive Assets

Updated Category News Views 3

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Continue Reading

Top 5 Most Recently Viewed Articles

Dementia Treatment Market Expected to Exceed USD 33 Billion

Updated Category News Views 92

Dementia Treatment Market Overview and Growth Forecast The global dementia treatment market is experiencing remarkable growth, with projections indicating it could exceed USD 33.54 billion in value. From an estimated USD 17.06 billion in 2023, this increase showcases a compound annual growth rate (CAGR) of 7.80% from 2024 through 2032. Several factors contribute to this...

Continue Reading
QOL Medical's CEO Donates $50,000 for Hurricane Relief

Updated Category News Views 116

QOL Medical's CEO Takes Action for Hurricane Recovery Frederick "Derick" Cooper, the CEO of QOL Medical, a prominent biopharmaceutical company focused on innovative treatments for rare gastrointestinal diseases, has recently made a generous donation of $50,000 to support recovery efforts following the devastation caused by Hurricane Helene. This contribution aims to...

Continue Reading
Wedbush Analysts Remain Bullish on Tech Stocks Amid Selloff

Updated Category News Views 71

Wedbush Analysts Remain Optimistic Despite Market Volatility Following the market's reopening after a long weekend, tech stocks faced significant pressure in a risk-averse environment. Nevertheless, analysts at Wedbush are holding firm in their positive outlook, maintaining a strong bullish stance on technology stocks. Market Trends and Tech Investment Opportunities...

Continue Reading
Verizon Business Empowers Small Enterprises with GenAI Assistant

Updated Category News Views 238

Introducing the Verizon Business Assistant for Small Businesses What you should know: The Verizon Business Assistant offers an immediate solution for small businesses, enabling them to save time while providing round-the-clock customer service through text messaging. This innovative platform empowers small enterprises to harness the same generative AI technology utilized...

Continue Reading
Rx To Go: Transforming Oncology with Patient-Centric Services

Updated Category News Views 244

Revolutionizing Cancer Care: Rx To Go's Journey Florida Cancer Specialists & Research Institute, LLC (FCS) has made significant strides in patient care through its medically integrated pharmacy, known as Rx To Go. This innovative service has offered personalized, compassionate support to nearly 16,000 patients in a single year, showcasing a commitment to enhancing patient...

Continue Reading